EPAX Names Goerlich Pharma as Distributor

Leading Omega-3 Supplier Appoints Distributor for German, Swiss and Austrian Markets

AALESUND, Norway (April 26, 2007) - EPAX AS, a world-leading supplier of marine-derived omega-3 EPA/DHA fatty acid concentrates, announced today that it has selected Goerlich Pharma International GmbH the exclusive distributor for its products in Germany, Switzerland and Austria. Goerlich Pharma is a German supplier of raw materials and finished products to the healthcare industry.

German-speaking markets have traditionally been dominated by low-priced natural fish and salmon oil products, unlike most of their neighbouring markets, which have already embraced high-quality omega-3 concentrates. However, EPAX is currently benefiting from a shift towards higher quality and concentrated omega-3 oils, resulting in strong sales growth for the company throughout the last few years.

"We are very pleased with this agreement and recognize Goerlich Pharma as a strong and experienced company," says Bjorn Refsum, CEO of EPAX AS. "Some of the important values driving the company include a focus on market/customer orientation and commitments to quality and technology. The Goerlich organization also has the competence to assist its customers from the 'idea stage' to finished product."

Mr. Refsum added that EPAX AS executives believe that Goerlich Pharma has the ability to convey the EPAX products accurately and professionally to the customers and end users in the German, Swiss and Austrian markets. Additionally, he noted that Goerlich Pharma is a good match for EPAX, both professionally and culturally.

"We are very proud about this appointment and cooperation with EPAX AS; emphasizing the value of indication-specific omega-3 concentrates is a great challenge for this growing market. Our relationship with EPAX allows us to effectively service customers who are seeking more options to address consumers' specific health concerns," says Franz Goerlich, owner and managing director of Goerlich Pharma International GmbH. "It is very important for us to work with a global player like EPAX AS, which provides the highest quality oil with an unmatched purity for this sensitive market."

The appointment comes at a time of increasing consumer awareness of the health benefits of the omega-3 fatty acids EPA and DHA due to a substantial body of scientific evidence supporting the use of the acids for cardiovascular, joint, mood and brain health.

"The healthcare industry, and its consumers, are increasingly realising the benefits of EPAX concentrates, such as the unmatched purity and consistently high quality level, the high content of essential omega-3 fatty acids, lack of unnecessary fats and the convenience of taking fewer capsules," said Haakon Brokke, sales manager of EPAX AS.

"The omega-3 market in Germany, Switzerland and Austria is still very generic, with fish and salmon oil being the most common," according to Mr. Brokke. Although, he says, "EPAX is looking forward to contributing to a shift in this market. All of our products are specifically designed to address common health concerns associated with the modern lifestyle. The EPAX product portfolio provides the healthcare industry with a variety of options for differentiation and allows the consumers to focus on individual health conditions. Our partnership with Goerlich Pharma enables EPAX to increase both our presence and activity level in order to handle the expected growth in these important markets."

Both EPAX and Goerlich Pharma will be exhibiting at the Vitafoods exhibition in Geneva, 8-10 May.

About EPAX AS:
EPAX AS is headquartered in Aalesund with a global sales office in Lysaker/Oslo, Norway. Its production facility in Aalesund is GMP-approved by the Norwegian Medicines Agency for manufacturing of API products. All of EPAX's business efforts reflect the company's core commitment: Purity | Quality | Innovation. These values represent EPAX's commitment to offering products that are safe, pure and of consistent quality. EPAX AS offers concentrated Omega-3 EPA/DHA oils in the business-to-business segment under the brand name EPAX, available in a wide range of top quality formulas with different EPA/DHA ratios focused on specific health conditions. EPAX is also available in TG or EE versions, including TG oils that are available in a deodorized TG/N version, which is virtually without taste and smell. For further information on EPAX AS, its products or clinical studies visit www.epax.com

About Goerlich Pharma International GmbH:
Goerlich Pharma International is an independent family owned company situated south-east of Munich, Germany. Since the company was founded in 1984, it has experienced dynamic growth and evolved from a marketer of PUFA vegetable oils into a custom manufacturer for finished products and with the division of Goerlich Health Ingredients a supplier of raw materials and speciality oils to the health food, pharmaceutical, cosmeceutical and pet food industries. For further information, visit www.goerlich-pharma.com

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.